Evolva and Cornelius Group Bring New Fermented Resveratrol to Market

636053014262030135grape.jpg

28 Jul 2016 --- Evolva have announced teaming up with Cornelius Group, an independent European distributor of high quality ingredients, for the marketing of resveratrol in certain European markets. Evolva’s resveratrol is produced via an innovative fermentation process using yeast.

Resveratrol is an ingredient found in red grapes, blueberries, nuts and other plants. There is already a significant body of evidence showing that resveratrol can produce a positive impact on healthy-ageing variables like heart health, bone health, and blood-glucose control. Scientists have also found evidence in key biomarkers that resveratrol might slow the progression of Alzheimer’s disease and mimic the effects of a calorie-restricted diet. Evolva’s resveratrol comes from a fermentation process, producing a high-purity ingredient free of any environmental contaminants.
 
Joy Thomas, technical manager, Cornelius Group said: “Most resveratrol on the market today comes from the Japanese knotweed plant. Evolva’s resveratrol is different and is manufactured via the fermentation of yeast, making it a pure product that is free of pesticides and other impurities that can be found in knotweed extracts.”
 
The fermented resveratrol from Evolva has a purity over 98 per cent and is suitable for a broad range of products from capsules and tablets for dietary supplements to more complex applications in foods, animal nutrition and personal care products. Cornelius has a strong position in these application markets. As the exclusive distributor for Evolva’s fermented resveratrol, Cornelius will supply the ingredient to the UK, Republic of Ireland, Denmark, Norway, Sweden and Finland foods market, countries with a total population 96 million.
 
Ms Thomas added “Consumers are now demanding formulations derived from natural sources. The clean label trend is now seen more as a consumer expectation, as well as an industry standard. Fermentation of Evolva’s resveratrol is a natural process and supports the current market and consumer trends”.
 
Evolva CEO Neil Goldsmith, said: “Much of the resveratrol sold today is made from knotweed, which results in a lack of control over the standard of crop. The benefit of using the fermentation process is that it ensures the quality of the ingredient. Manufacturing resveratrol through the fermentation of yeast offers us, and our customers, peace of mind as it’s made from natural and sustainable feedstocks and has a stable, traceable and reliable supply chain.”
 
This distribution agreement does not change Evolva’s revenue guidance for 2016.
 
Earlier this year, Evolva announced that the European Patent Office granted the Company patent number 2742142, intellectual property pivotal to the commercial expansion of and broader access to the best-tasting stevia-sweeteners made possible through the introduction of yeast fermentation-derived steviol glycosides. Evolva currently has 54 patents pending around the world related to yeast fermentation-derived steviol glycosides and they now have four commercially relevant stevia sweetener patents granted.

Related Articles

From TWOFI

Inside Tomorrow’s Nutrition Shelf

03 Aug 2017 --- Key suppliers offer their thoughts on the trends that will drive the nutritionals market forward. What is the future for personalized nutrition and which condition specific nutrition areas are on trend?

From TWOFI

View From the Top: Simon Strauch, BASF

03 Aug 2017 --- The Human Genome Project’s revelation in 2003 that there are around 20,500 human genes was a milestone in science and health. Now, as individuals all over the world strive to live longer more healthily, personalized nutrition is being eyed as one breakthrough that will allow them to achieve this goal.

From TWOFI

Creating Optimal Clean Label Supplements

03 Aug 2017 --- For decades, gelatin has been the safe and only choice for hard and soft capsule manufacturers.

From TWOFI

Probiotic Innovation: New Application Hopes

03 Aug 2017 --- Michael Bush, President & CEO of probiotic ingredient supplier Ganeden, discusses challenges and opportunities in the probiotic market and the company’s latest innovations.

From TWOFI

VIEW FROM THE TOP: Malcolm Sheil, Taste and Nutrition Division President and CEO Europe, Kerry

21 Jun 2017 --- Kerry Group’s new Taste and Nutrition Division President and CEO of Europe, Malcolm Sheil has just been permanently appointed to the role, following a period serving as Interim President.

More Articles